Drawing for TDI

USPTO serial 99208486

TDI

Reviewed by CopyMark Law Group

Reg. 8210268Status 700Registered
Filing date
Status date
Registration date
Apr 14, 2026
Examiner
ZELLNER, SIERRA E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TDI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

4101 Lake Boone Trail, Suite 3004101 Lake Boone Trail Suite 300Raleigh, NC 27607

Goods and services

ClassDescriptionStatusFirst use
035Database management and data processing services in the pharmaceutical and life sciences fields; business data analytics and data management services being data processing for business purposes in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for clinical trial purposes for business purposesACTIVEMay 4, 2025
042Scientific data analysis, namely, analysis of clinical trial data in the pharmaceutical, biotechnology and life sciences fields; Scientific research services, namely, accessing, collecting, managing, tracking, analyzing, and reporting research data in the pharmaceutical and life sciences fields; Scientific research consulting services, namely, collecting, managing, and analyzing clinical trial data; Consulting services for others in the field of design, planning, and implementation of clinical trials, clinical trial simulation, and clinical trial data review; Contract research organization (CRO) services, namely, scientific research in the nature of conducting clinical trials for investigational drugs of biotech and pharmaceutical companies for others, and quality assurance services for others in the fields of data management, electronic data capture (EDC) database programming of clinical trial, and data analytics for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry and the biotechnology industry; Providing quality assurance services in the pharmaceutical and biotechnology fields for othersACTIVEMay 4, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 14, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2025DOCKASSIGNED TO EXAMINER—
Oct 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance